US 12036269
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
granted A61KA61K31/198A61K31/4415
Quick answer
US patent 12036269 (Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria) held by The Board of Regents of the University of Texas System expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/198, A61K31/4415, A61K38/51, A61K47/60